Skip to content
YTTRANDE (2026/0196(BUD))

Europeiska unionens allmänna budget för budgetåret 2027 – alla avsnitt

FEMM-AD-789930

Utskottet för kvinnors rättigheter och jämställdhet · Rapporteur: Raquel García HermidaVan Der Walle

Official HTML ↗ PDF DOCX
✦ In shortFull text
✦ In short · AI summary of this text, generated 25 Sept 2026

Written by a language model from the full text only; every figure comes from the text. The paragraph links open the paragraph a statement rests on — check the text itself before relying on it.

The Committee on Women's Rights and Gender Equality calls on the Committee on Budgets to include its proposals in the 2027 EU budget resolution. It asks for gender mainstreaming across all budget stages, dedicated funding for gender equality, and support for sexual and reproductive health and rights. It calls for sufficient funding for the Daphne programme, EIGE, CERV, ESF+, EU4Health and the Justice programme, and for a strong twin-track approach in external action under GAP III and GAP IV. It asks Member States to implement the Pay Transparency, Combating Violence Against Women and revised Victims' Rights Directives, and calls for funding for infertility services, cancer care and gender-specific health research. It calls for increased funding for gender equality amid backlash, for withholding EU funds from actors undermining rights, and for the Daphne strand to remain separate in the next MFF.

Committee position. The Committee on Women's Rights and Gender Equality calls on the Committee on Budgets to incorporate its proposals into the 2027 budget resolution, asking for gender mainstreaming, dedicated gender equality funding and support for sexual and reproductive health and rights.

Key points

  1. Calls for gender mainstreaming at all budget stages, gender impact assessments ex ante and ex post, earmarked funding and specific gender equality objectives in the next MFF.
  2. Calls for mandatory collection, reporting and evaluation of comparable gender-disaggregated data, and further development of the gender tracking methodology.
  3. Calls on the Commission to support Member States in implementing its reply to the My Voice My Choice initiative, and for increased EU4Health funding for abortion access.
  4. Calls on the Commission and Member States to improve equal access to infertility prevention, diagnosis, medically assisted reproduction and psychosocial support through ESF+ and EU4Health.
  5. Calls on Member States to implement the Pay Transparency, Combating Violence Against Women and revised Victims' Rights Directives, with sufficient 2027 funding for Justice, CERV+, Daphne and ESF+.
  6. Calls for a twin-track approach in Global Europe, with GAP III and GAP IV including measurable targets, annual reporting and the ambition that 85% of external spending contributes to gender equality and 5% has it as a principal objective.
  7. Calls for adequate funding for Europe's Beating Cancer Plan, focusing on breast, ovarian and other gynaecological cancers, earlier diagnosis and equitable access to testing and treatments.
  8. Calls for increased funding for gender equality and the Daphne programme, for Daphne to remain a separate strand in the next MFF, and for the AgoraEU envelope to increase to €10,72 billion.
  9. Calls for at least 16% of the AgoraEU budget and Daphne strand to go to preventing and combating gender-based violence, and for funding to be withheld from actors undermining rights.
  10. Calls for ESF+ to promote women's employment, affordable childcare and long-term care, and welcomes the Commission's announced European Care Deal to be published in 2027.
  11. Calls for EU4Health funding for research into gender-specific health conditions including infertility, oncofertility, menopause, endometriosis, fibroids and trans-specific health care.
  12. Calls on EIGE to continue providing comparable data and notes it needs adequate funding and staff for its additional responsibilities under several directives and the Cybersecurity Regulation.

Who is affected

  • Member States, which are asked to implement the Pay Transparency, Combating Violence Against Women and revised Victims' Rights Directives and use ESF+ for SRHR.
  • The Commission, which is asked to support Member States on the My Voice My Choice decision and to explore the core mission of EU fund recipients.
  • The European Institute for Gender Equality (EIGE), which is asked to continue providing data and needs adequate funding and staff.
  • Civil society organisations active in women's rights and SRHR, which should receive support and funding under AgoraEU and Daphne.
  • People facing infertility, who should get equal access to prevention, diagnosis, medically assisted reproduction and psychosocial support.

Figures and deadlines

  • €10,72 billion, the proposed increase to the overall AgoraEU envelope.
  • At least 16%, the share of the AgoraEU budget and Daphne strand for preventing and combating gender-based violence.
  • 85% of external spending should contribute to gender equality and 5% should have it as a principal objective.
  • 14 June 2027, the deadline to transpose Directive (EU) 2024/1385 on combating violence against women and domestic violence.
  • 7 June 2026, the deadline by which Directive (EU) 2023/970 on pay transparency had to be transposed.
  • Over 1.1 million valid signatures gathered by the My Voice, My Choice European citizens' initiative, reaching thresholds in 19 Member States.

Legal basis: Article 8 of the Treaty on the Functioning of the European Union (TFEU).